- Home
- NBIX vs JEF Comparison
NBIX vs JEF Comparison
Compare NBIX & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- JEF
- Stock Information
- Founded
- NBIX 1992
- JEF 1968
- Country
- NBIX United States
- JEF United States
- Employees
- NBIX N/A
- JEF N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- JEF Investment Bankers/Brokers/Service
- Sector
- NBIX Health Care
- JEF Finance
- Exchange
- NBIX Nasdaq
- JEF Nasdaq
- Market Cap
- NBIX 13.2B
- JEF 11.0B
- IPO Year
- NBIX 1996
- JEF N/A
- Fundamental
- Price
- NBIX $139.60
- JEF $64.67
- Analyst Decision
- NBIX Strong Buy
- JEF Buy
- Analyst Count
- NBIX 18
- JEF 4
- Target Price
- NBIX $160.94
- JEF $61.00
- AVG Volume (30 Days)
- NBIX 782.5K
- JEF 1.4M
- Earning Date
- NBIX 10-29-2025
- JEF 09-24-2025
- Dividend Yield
- NBIX N/A
- JEF 2.47%
- EPS Growth
- NBIX 2.97
- JEF 47.33
- EPS
- NBIX 3.39
- JEF 2.66
- Revenue
- NBIX $2,509,900,000.00
- JEF $6,867,621,000.00
- Revenue This Year
- NBIX $20.66
- JEF N/A
- Revenue Next Year
- NBIX $14.64
- JEF $12.52
- P/E Ratio
- NBIX $40.91
- JEF $24.41
- Revenue Growth
- NBIX 18.42
- JEF 19.44
- 52 Week Low
- NBIX $84.23
- JEF $39.28
- 52 Week High
- NBIX $154.61
- JEF $82.68
- Technical
- Relative Strength Index (RSI)
- NBIX 68.09
- JEF 70.64
- Support Level
- NBIX $133.62
- JEF $58.00
- Resistance Level
- NBIX $137.03
- JEF $60.25
- Average True Range (ATR)
- NBIX 2.36
- JEF 1.51
- MACD
- NBIX 0.83
- JEF 0.43
- Stochastic Oscillator
- NBIX 97.44
- JEF 95.08
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About JEF Jefferies Financial Group Inc.
Jefferies Financial Group Inc is a full-service investment banking and capital markets firm. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers. Operates geographically in America, Europe and Middle East, Asia Pasific.